{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:21:46Z","timestamp":1793161306564,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T00:00:00Z","timestamp":1531526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10238-018-0516-3","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T06:54:30Z","timestamp":1531551270000},"page":"495-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome"],"prefix":"10.1007","volume":"18","author":[{"given":"Marcelo C\u00e2ndido","family":"de S\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a Name Colado","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano Aparecido","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Mayumi Veiga","family":"Iriyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neide Tomimura","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Frizon","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamires","family":"Flauzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Alexandre","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcell Alysson Batisti","family":"Lozovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna Maria Vissoci","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaias","family":"Dichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,14]]},"reference":[{"issue":"9","key":"516_CR1","doi-asserted-by":"publisher","first-page":"e1887","DOI":"10.1038\/cddis.2015.246","volume":"6","author":"MS Chimenti","year":"2015","unstructured":"Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015;6(9):e1887.","journal-title":"Cell Death Dis"},{"issue":"23","key":"516_CR2","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"key":"516_CR3","first-page":"368","volume":"35","author":"F Angelotti","year":"2017","unstructured":"Angelotti F, Parma A, Cafaro G, Capecchi R, Alunno A, Puxeddu I. One year in review 2017: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2017;35:368\u201378.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"516_CR4","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1038\/s41598-017-05759-2","volume":"7","author":"F Ursini","year":"2017","unstructured":"Ursini F, Leporini C, Bene F, D\u2019Angelo S, Mauro D, Russo E, et al. Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. Sci Rep. 2017;7(1):5346.","journal-title":"Sci Rep"},{"issue":"6","key":"516_CR5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.1780400602","volume":"40","author":"CF Mojcik","year":"1997","unstructured":"Mojcik CF, Shevach EM. Adhesion molecules. Arthritis Rheum. 1997;40(6):991\u20131004.","journal-title":"Arthritis Rheum"},{"key":"516_CR6","first-page":"1","volume":"2016","author":"X Yang","year":"2016","unstructured":"Yang X, Chang Y, Wei W. Endothelial dysfunction and inflammation: immunity in rheumatoid arthritis. Mediators Inflamm. 2016;2016:1\u20139.","journal-title":"Mediators Inflamm"},{"key":"516_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/346425a0","volume":"346","author":"TA Springer","year":"1990","unstructured":"Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425\u201334.","journal-title":"Nature"},{"key":"516_CR8","doi-asserted-by":"publisher","first-page":"340296","DOI":"10.1155\/2012\/340296","volume":"2012","author":"C Wai Wong","year":"2012","unstructured":"Wai Wong C, Dye DE, Coombe DR. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol. 2012;2012:340296.","journal-title":"Int J Cell Biol"},{"issue":"3","key":"516_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","volume":"12","author":"M Prasad","year":"2015","unstructured":"Prasad M, Hermann J, Gabriel SE, Weyand CM, Mulvagh S, Mankad R, et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015;12(3):168\u201376.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"516_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/acr.20322","volume":"63","author":"E Bartoloni","year":"2011","unstructured":"Bartoloni E, Shoenfeld Y, Gerli R. Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res. 2011;63(2):178\u201383.","journal-title":"Arthritis Care Res"},{"issue":"9","key":"516_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/rheumatology\/34.9.814","volume":"34","author":"AD Blann","year":"1995","unstructured":"Blann AD, Herrick A, Jayson MI. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol. 1995;34(9):814\u20139.","journal-title":"Br J Rheumatol"},{"issue":"0300\u20139742 (Prin","key":"516_CR12","first-page":"296","volume":"27","author":"DJ Veale","year":"1998","unstructured":"Veale DJ, Maple C, Kirk G, McLaren M, Belch JJ. Soluble cell adhesion molecules-P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol. 1998;27(0300\u20139742 (Print)):296\u20139.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"516_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10067-004-0909-4","volume":"23","author":"A Ate\u015f","year":"2004","unstructured":"Ate\u015f A, Kinikli G, Turgay M, Duman M. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Clin Rheumatol. 2004;23(5):421\u20135.","journal-title":"Clin Rheumatol"},{"key":"516_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3892\/etm.2015.2635","volume":"10","author":"L Wang","year":"2015","unstructured":"Wang L, Ding Y, Guo X, Zhao Q. Role and mechanism of vascular cell adhesion molecule-1 in the development of rheumatoid arthritis. Exp Ther Med. 2015;10:1229\u201333.","journal-title":"Exp Ther Med"},{"issue":"9468","key":"516_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"516_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2036.2005.02589.x","volume":"22","author":"A Zambon","year":"2005","unstructured":"Zambon A, Pauletto P, Crepaldi G. Review article: the metabolic syndrome\u2013a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther. 2005;22(Suppl 2):20\u20133.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"516_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-2005-861363","volume":"37","author":"MT Schram","year":"2005","unstructured":"Schram MT, Stehouwer CD. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res. 2005;37(1):49\u201355.","journal-title":"Horm Metab Res"},{"issue":"11","key":"516_CR18","first-page":"2545","volume":"27","author":"EF Kamper","year":"2000","unstructured":"Kamper EF, Kopeikina LT, Trontzas F, Potamianou A, Tsakiroglou E, Stavridis JC. The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis. J Rheumatol. 2000;27(11):2545\u201350.","journal-title":"J Rheumatol"},{"issue":"SUPPL. 1","key":"516_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1538-7836.2007.02464.x","volume":"5","author":"RL Medcalf","year":"2007","unstructured":"Medcalf RL. Fibrinolysis, inflammation, and regulation of the plasminogen activating system. J Thromb Haemost. 2007;5(SUPPL. 1):132\u201342.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"516_CR20","first-page":"373","volume":"24","author":"MA Gonzales-Gay","year":"2006","unstructured":"Gonzales-Gay MA, Garcia-Unzueta MT, De Matias JM, Gonzales-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, et al. Influence of anti-TNF-\u03b1 infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2006;24(4):373\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"516_CR21","doi-asserted-by":"publisher","first-page":"R158","DOI":"10.1186\/ar3116","volume":"12","author":"A S\u00f6dergren","year":"2010","unstructured":"S\u00f6dergren A, Karp K, Boman K, Eriksson C, Lundstr\u00f6m E, Smedby T, et al. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther. 2010;12(4):R158.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"516_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3109\/03009742.2011.626443","volume":"41","author":"V Cunha Da","year":"2012","unstructured":"Da Cunha V, Brenol C, Brenol J, Fuchs S, Arlindo E, Melo I, et al. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol. 2012;41(3):186\u201391.","journal-title":"Scand J Rheumatol"},{"key":"516_CR23","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"516_CR24","doi-asserted-by":"crossref","unstructured":"Prevoo MLL, MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum. 1995,38(1):44-48.","DOI":"10.1002\/art.1780380107"},{"issue":"1","key":"516_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"MLL Prevoo","year":"1995","unstructured":"Prevoo MLL, van\u00b4t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM, Prevoo MLL. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"key":"516_CR26","first-page":"151","volume":"62","author":"J Fransen","year":"2004","unstructured":"Fransen J, Welsing P, Keijzer RD, Riel PV. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis. 2004;62:151.","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"516_CR27","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"issue":"1","key":"516_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y, Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc B"},{"key":"516_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2174\/1381612053381972","volume":"11","author":"MV Volin","year":"2005","unstructured":"Volin MV. Soluble adhesion molecules in the pathogenesis of rheumatoid arthritis. Curr Pharm Des. 2005;11:633\u201353.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"516_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2007.11.007","volume":"199","author":"L G\u00f3mez Rosso","year":"2008","unstructured":"G\u00f3mez Rosso L, Ben\u00edtez MB, Fornari MC, Berardi V, Lynch S, Schreier L, et al. Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome. Atherosclerosis. 2008;199(2):415\u201323.","journal-title":"Atherosclerosis"},{"issue":"2","key":"516_CR31","first-page":"165","volume":"19","author":"MN Kolopp-Sarda","year":"2001","unstructured":"Kolopp-Sarda MN, Guillemin F, Chary-Valckenaere I, B\u00e9n\u00e9 MC, Pourel J, Faure GC. Longitudinal study of rheumatoid arthritis patients discloses sustained elevated serum levels of soluble CD106 (V-CAM). Clin Exp Rheumatol. 2001;19(2):165\u201370.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"516_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/rheumatology\/36.2.164","volume":"36","author":"AJ Littler","year":"1997","unstructured":"Littler AJ, Buckley CD, Wordworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol. 1997;36(2):164\u20139.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"516_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/clin.1993.1098","volume":"68","author":"KP Machold","year":"1993","unstructured":"Machold KP, Kiener HP, Graninger W, Graninger WB. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol. 1993;68(1):74\u20138.","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"516_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/BF02238960","volume":"16","author":"LT Kopeikina","year":"1997","unstructured":"Kopeikina LT, Kamper EF, Koutsoukos V, Bassiacos Y, Stavridis I. Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity. Clin Rheumatol. 1997;16(3):254\u201360.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"516_CR35","first-page":"875","volume":"29","author":"S Wallberg-Jonsson","year":"2002","unstructured":"Wallberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert K, Rantap\u00e4\u00e4-Dahlqvist SJ. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol. 2002;29(5):875\u201382.","journal-title":"J Rheumatol"},{"issue":"8","key":"516_CR36","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/sj.ijo.0803189","volume":"30","author":"I Mertens","year":"2006","unstructured":"Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, Van Gaal LF. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes. 2006;30(8):1308\u201314.","journal-title":"Int J Obes"},{"issue":"SUPPL.2","key":"516_CR37","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0167-4943(09)70012-3","volume":"49","author":"YY Chou","year":"2009","unstructured":"Chou YY, Sheu WHH, Tang YJ, Chen YM, Liao SC, Chuang YW, et al. Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan. Arch Gerontol Geriatr. 2009;49(SUPPL.2):S41\u20135.","journal-title":"Arch Gerontol Geriatr"},{"key":"516_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/541467","volume":"2011","author":"CS Coffey","year":"2011","unstructured":"Coffey CS, Asselbergs FW, Hebert PR, Hillege HL, Li Q, Moore JH, et al. The association of the metabolic syndrome with PAI-1 and t-PA Levels. Cardiol Res Pract. 2011;2011:1\u20138.","journal-title":"Cardiol Res Pract"},{"key":"516_CR39","first-page":"63","volume":"42","author":"S Bilgili","year":"2008","unstructured":"Bilgili S, Celebiler AC, Dogan A, Karaca B. Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr Regul. 2008;42:63\u20138.","journal-title":"Endocr Regul"},{"issue":"3","key":"516_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/hmbci-2015-0039","volume":"24","author":"AK Ahirwar","year":"2015","unstructured":"Ahirwar AK, Jain A, Singh A, Goswami B, Bhatnagar MK, Bhatacharjee J. The study of markers of endothelial dysfunction in metabolic syndrome. Horm Mol Biol Clin Investig. 2015;24(3):131\u20136.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"1","key":"516_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7150\/ijms.13800","volume":"13","author":"K Srikanthan","year":"2016","unstructured":"Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population. Int J Med Sci. 2016;13(1):25\u201338.","journal-title":"Int J Med Sci"},{"key":"516_CR42","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/01.ATV.0000242905.41404.68","volume":"26","author":"MC Alessi","year":"2006","unstructured":"Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome links, causes, and consequences. Arterioscler Thromb Vasc Biol. 2006;26:2200\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Das 28","key":"516_CR43","first-page":"1","volume":"2016","author":"NT Costa","year":"2016","unstructured":"Costa NT, Iriyoda TMV, Kallaur AP, Delongui F, Alfieri DF, Lozovoy MAB, et al. Influence of insulin resistance and TNF-\u03b1 on the inflammatory process, oxidative stress, and disease activity in patients with rheumatoid arthritis. Oxid Med Cell Longev. 2016;2016(Das 28):1\u20139.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"516_CR44","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1089\/ars.2010.3522","volume":"15","author":"JM Cook-Mills","year":"2011","unstructured":"Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal. 2011;15(6):1607\u201338.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"516_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/01.ATV.0000106321.63667.24","volume":"24","author":"JJ Chiu","year":"2004","unstructured":"Chiu JJ, Lee PL, Chen CN, Lee CI, Chang SF, Chen LJ, et al. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-\u03b1 in endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24(1):73\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"516_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/03009740310004054","volume":"33","author":"M Ugur","year":"2004","unstructured":"Ugur M, Yildirim K, Kiziltunc A, Erdal A, Karatay S, Senel K. Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity. Scand J Rheumatol. 2004;33(4):239\u201343.","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"516_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/ard.61.9.804","volume":"61","author":"PA Klimiuk","year":"2002","unstructured":"Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, et al. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis. 2002;61(9):804\u20139.","journal-title":"Ann Rheum Dis"},{"key":"516_CR48","doi-asserted-by":"crossref","unstructured":"Klimek E, Skalska A, Kwa\u015bny-Krochin B, Surdacki A, Sulicka J, Korkosz M, et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Mediators Inflamm. 2014;2014.","DOI":"10.1155\/2014\/681635"},{"key":"516_CR49","first-page":"943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.","journal-title":"Cardiol Res Pract"},{"key":"516_CR50","doi-asserted-by":"publisher","first-page":"204800401663337","DOI":"10.1177\/2048004016633371","volume":"5","author":"TS Han","year":"2016","unstructured":"Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016;5:204800401663337.","journal-title":"JRSM Cardiovasc Dis"},{"issue":"1","key":"516_CR51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12026-017-8960-9","volume":"66","author":"BM Scavuzzi","year":"2018","unstructured":"Scavuzzi BM, Sim\u00e3o ANC, Iryioda TMV, et al. Increased lipid and protein oxidation and lowered antioxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules and Th1 and Th17 immune shift. Immunol Res. 2018;66(1):158\u201371.","journal-title":"Immunol Res"},{"issue":"12","key":"516_CR52","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"516_CR53","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710\u20138.","journal-title":"Am J Epidemiol."},{"key":"516_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12874-016-0267-3","volume":"16","author":"M van Smeden","year":"2016","unstructured":"van Smeden M, de Groot JHA, Moons KGM, Collins GS, Altman DG, Eijkemans MJC, et al. No rationale for 1 variable per 10 events criterion for binary logistic regression analysis. BMC Med Res Methodol. 2016;16:163.","journal-title":"BMC Med Res Methodol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-018-0516-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T06:48:32Z","timestamp":1720421312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-018-0516-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,14]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["516"],"URL":"https:\/\/doi.org\/10.1007\/s10238-018-0516-3","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,14]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the participants included in this study provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}